ArticleRSC advances2025

High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs).

Phongthon Kanjanasirirat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.